Evidence map›Paper›PMID 32325703›Full record

ArticleCancers2020

Zikavirus

Maibritt Kretschmer, Patrycja Kadlubowska, Daniel Hoffmann, Birco Schwalbe, Heidi Auerswald, Michael Schreiber

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Zika Virus: A New Therapeutic Candidate for Glioblastoma Treatment.International journal of molecular sciences · 2021
    Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Maibritt KretschmerDepartment of Virology, Bernhard-Nocht Institute for Tropical Medicine, D-20359 Hamburg, Germany.
Patrycja KadlubowskaDepartment of Virology, Bernhard-Nocht Institute for Tropical Medicine, D-20359 Hamburg, Germany.
Daniel HoffmannDepartment of Virology, Bernhard-Nocht Institute for Tropical Medicine, D-20359 Hamburg, Germany.
Birco SchwalbeDepartment of Neurosurgery, Asklepios Klinik Nord-Heidberg, Asklepios Kliniken Hamburg GmbH, D-22417 Hamburg, Germany.
Heidi AuerswaldDepartment of Virology, Bernhard-Nocht Institute for Tropical Medicine, D-20359 Hamburg, Germany.ORCID 0000-0002-4717-7618
Michael SchreiberDepartment of Virology, Bernhard-Nocht Institute for Tropical Medicine, D-20359 Hamburg, Germany.
Bernhard Nocht Institute for Tropical Medicine · DEAsklepios Kliniken Hamburg · DEInstitut Pasteur du Cambodge · KH

Funding

Werner Otto Stiftung 6/95
6 · The paper itself

Abstract

Glioblastoma multiforme is the most lethal type of brain tumor that is not yet curable owing to its frequent resurgence after surgery. Resistance is mainly caused by the presence of a subpopulation of tumor cells, the glioma stem cells (GSCs), which are highly resistant to radiation and chemotherapy. In 2015, Zikavirus (ZIKV)-induced microcephaly emerged in newborns, indicating that ZIKV has a specific neurotropism. Accordingly, an oncolytic tropism for infecting GSCs was demonstrated in a murine tumor model. Like other flaviviruses, ZIKV is enveloped by two proteins,

Indexed as

glioma stem cellsHIV-1HIV-1 packaging systemneurotropismoncolytic virusespseudotyped virusvirotherapyzika virus

Identifiers

PMID32325703
PMCPMC7226176
OpenAlexW3017127518

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.